Anesthesia and analgesia
-
Anesthesia and analgesia · Jul 1998
Comparative Study Clinical TrialComparison of plasma lidocaine concentrations after injection of a fixed small volume in the stellate ganglion, the lumbar epidural space, or a single intercostal nerve.
We measured the plasma lidocaine concentrations after stellate ganglion block (SGB) and compared them with those after intercostal nerve block (ICNB) and epidural block (EB) using identical doses of lidocaine. Thirty patients undergoing SGB (n = 10), ICNB (n = 10), or EB (n = 10) in our pain clinic participated in this study. Six milliliters of 1% lidocaine was used for all nerve blocks. SGB was performed at the C6 transverse process, ICNB was performed on a single intercostal nerve, and epidural lidocaine was injected through the lumbar epidural catheter. After drug administration, venous blood samples were taken from an indwelling catheter in the arm every minute for the first 10 min and 15, 20, 30, 45, and 60 min thereafter. Plasma lidocaine concentrations were measured by using an enzyme immunoassay method. The SGB group showed significantly higher peak plasma lidocaine concentrations than other groups (SGB 1.65 +/- 0.21 microgram/mL, ICNB 0.89 +/- 0.12 microgram/mL, EB 0.91 +/- 0.19 microgram/mL; P < 0.01). The SGB group reached peak levels significantly faster than the other groups (SGB 3.4 +/- 1.0 min, ICNB 7.9 +/- 1.5 min, EB 6.9 +/- 0.7 min; P < 0.01). We conclude that the plasma lidocaine concentrations after SGB were higher than those after ICNB and EB when using small, equal doses of lidocaine. The high and rapid peak plasma lidocaine concentrations after SGB are probably related to the high vascularity of the injection site. ⋯ Higher plasma concentrations of local anesthetics are reportedly obtained after multiple intercostal nerves blocks compared with those after other types of nerve blocks. Our results, however, showed that the peak plasma concentrations after stellate ganglion block were higher and faster than those after a single intercostal nerve block.
-
Anesthesia and analgesia · Jul 1998
Randomized Controlled Trial Clinical TrialClonidine added to the anesthetic solution enhances analgesia and improves oxygenation after intercostal nerve block for thoracotomy.
We evaluated the effect of adding clonidine to bupivacaine on postoperative pain control and oxygenation after intercostal nerve blockade (ICB) for thoracotomy, and attempted to distinguish a systemic from a local effect of clonidine. ICB with 2 mg/kg 0.5% bupivacaine was performed in 36 patients undergoing thoracotomy. Patients were randomized to one of three groups: 1) a control group that received bupivacaine with saline for ICB and an IM injection of saline, 2) an IM group that received bupivacaine with saline for ICB and an IM injection of 2 micrograms/kg clonidine, and 3) a block group that received bupivacaine with 2 micrograms/kg clonidine for ICB and an IM injection of saline. Blood gases, visual analog scale (VAS) scores, and analgesic demand were determined hourly for 8 h after arrival in the postoperative care unit (PCU). Patients in the block group had significantly lower VAS scores, higher arterial oxygen tension, and lower analgesic demand for the first 4 h in the PCU, compared with the two other groups. No difference was noted thereafter. We conclude that the addition of clonidine to bupivacaine for ICB leads to a short-term effect enhancing postoperative pain control and improving arterial oxygenation, probably mediated by a direct effect on the nerves. ⋯ Severe pain after thoracotomy can lead to impaired ventilation. We studied the effect of adding clonidine to bupivacaine for intercostal nerve blockade after thoracotomy. Clonidine administered directly on the nerves enhanced analgesia and improved oxygenation for a short time compared with systemic administration or control.
-
Anesthesia and analgesia · Jul 1998
Randomized Controlled Trial Clinical TrialMagnesium sulfate reduces intra- and postoperative analgesic requirements.
In a randomized, double-blind study with two parallel groups, we assessed the analgesic effect of perioperative magnesium sulfate administration in 46 ASA physical status I or II patients undergoing arthroscopic knee surgery with total i.v. anesthesia. The patients received either magnesium sulfate 50 mg/kg preoperatively and 8 mg.kg-1.h-1 intraoperatively or the same volume of isotonic sodium chloride solution i.v. Anesthesia was performed with propofol (2 mg/kg for induction, 6-8 mg.kg-1.h-1 for maintenance), fentanyl (3 micrograms/kg for induction), and vecuronium (0.1 mg/kg for intubation). Intraoperative pain was defined as an increase of mean arterial blood pressure and heart rate of more than 20% from baseline values after the induction of anesthesia and was treated with bolus fentanyl (1-2 micrograms/kg). Postoperative analgesia was achieved with fentanyl (0.5 microgram/kg) and evaluated using the pain visual analog scale for 4 h. During the intraoperative and postoperative periods, patients in the magnesium group required significantly less fentanyl than those in the control group (control group 0.089 +/- 0.02 microgram.kg-1.min-1 versus magnesium group 0.058 +/- 0.01 microgram.kg-1.min-1; P < 0.05 and control group 0.021 +/- 0.013 microgram.kg-1.min-1 and magnesium group 0.0031 +/- 0.0018 microgram.kg-1.min-1; P < 0.01 for intraoperative and postoperative periods, respectively). We conclude that, in a clinical setting with almost identical levels of surgical stimulation, i.v. magnesium sulfate administration reduces intraoperative and postoperative analgesic requirements compared with isotonic sodium chloride solution administration. ⋯ The perioperative administration of i.v. magnesium sulfate reduces intra- and postoperative analgesic requirements in patients with almost identical levels of surgical stimulus. Our results demonstrate that magnesium can be an adjuvant to perioperative analgesic management.
-
Anesthesia and analgesia · Jul 1998
Randomized Controlled Trial Clinical TrialDose-response of ketorolac as an adjunct to patient-controlled analgesia morphine in patients after spinal fusion surgery.
This randomized, blind study was designed to determine the appropriate dose of ketorolac (a drug used as a supplement to opioids) to administer to patients who have undergone spinal stabilization surgery. The ketorolac was administered every 6 h, in addition to patient-controlled analgesia (PCA) with morphine, to 70 inpatients undergoing spine stabilization by one surgeon. The study was performed to determine the analgesic efficacy and incidence of side effects with different doses of ketorolac. The patients were divided into seven groups. They were given either i.v. saline (control group) or i.v. ketorolac (5, 7.5, 10, 12.5, 15, or 30 mg) every 6 h. The outcomes measured included pain scores, 24-h morphine usage, level of sedation, and side effect profile six times during the first 24 h postoperatively. The total dose of morphine was significantly larger in the control and 5 mg ketorolac groups than in the other five groups. Morphine consumption was similar in all groups receiving > or = 7.5 mg of ketorolac. The pain scores were significantly higher in the control group than in some of the larger dose groups at three of the study intervals. The 5 mg group had higher pain scores than the other groups at most of the time intervals studied. There were no significant differences in pain scores among the other five groups. Sedation scores were higher (i.e., patients were more sedated) in the control group than in the other six groups at three of the time periods. We conclude that the administration of ketorolac 7.5 mg every 6 h has a morphine-sparing effect equivalent to that of larger doses in patients undergoing spine stabilization surgery. Using larger doses of ketorolac did not result in less somnolence, lower morphine use, or less pain. We recommend that ketorolac 7.5 mg be given every 6 h to patients undergoing spinal fusion surgery in addition to PCA morphine. ⋯ Using smaller doses of ketorolac (e.g., 7.5 mg every 6 h) as a supplement to morphine patient-controlled analgesia is as effective as larger doses in patients who have undergone spine stabilization surgery.